Welcome to the ATTD 2022 Interactive Program

The conference will officially run on Central European Summer Time (UTC+2) - Barcelona Time

To convert the conference times to your local time Click Here


 

Displaying One Session

Session Type
Parallel Session
Date
Fri, 29.04.2022
Session Time
09:00 - 10:00
Room
Hall 115

Accuracy of glucose sensors in patients with acute or chronic comorbidities

Session Type
Parallel Session
Date
Fri, 29.04.2022
Session Time
09:00 - 10:00
Room
Hall 115
Lecture Time
09:00 - 09:20

Abstract

Abstract Body

Continuous glucose monitors (CGMs) have become part of routine diabetes care in the last years. The use of CGM for the management of diabetes in special patient groups with comorbidities, in hospitals and nursing homes is of great interest and gets additionally stimulated by coronavirus disease that necessitates remote monitoring. However, these patient groups or settings are usually not represented in large studies on reliability and accuracy of CGM devices. Different physiological processes and possibly interfering medication might impair CGM performance. In the last years a couple of small studies that evaluated the accuracy of CGM in different patient groups and settings, like patients undergoing dialysis or ICU patients, were published. The presentation will provide a brief overview about studies and study results and will discuss the consequences of these results for CGM use in such patient groups.

Hide

Implementation of continuous glucose monitoring for the management of diabetes in hospitals and nursing homes

Session Type
Parallel Session
Date
Fri, 29.04.2022
Session Time
09:00 - 10:00
Room
Hall 115
Lecture Time
09:20 - 09:40

Closed-loop insulin therapy in hospitals

Session Type
Parallel Session
Date
Fri, 29.04.2022
Session Time
09:00 - 10:00
Room
Hall 115
Lecture Time
09:40 - 10:00

Abstract

Abstract Body

Fully automated closed-loop insulin delivery in the inpatient setting has been shown to be safe and effective. The use of inpatient closed-loop therapy is associated with significantly improved glycaemic control compared to standard insulin therapy without increasing the risk of hypoglycaemia, including in those requiring nutrition support (enteral and parenteral nutrition) or haemodialysis during their admission. Closed-loop systems may provide an important opportunity to address the challenges associated with inpatient diabetes management.

In this talk we review the available evidence from randomised clinical trials, and report on our experience of implementation of inpatient closed-loop technology in a real-world setting. We will discuss key considerations for healthcare providers to adopt inpatient closed-loop technology.

Hide